Mounjaro, the brand name for tirzepatide, is an FDA-approved medication that works on both GLP-1 and GIP receptors
If prescribed, your medication can be delivered directly to your door with ongoing support from your care team
Kouichi Tamura has received honoraria/lecture fee from AstraZeneca, Novartes, Bayer, Otsuka Pharmaceutical, Boehringer Ingelheim, Fuji Pharma, Kyowa Kirin, Ono Pharmaceutical, Sanwa Kagaku, Mochida Pharmaceutical, Kowa, Eli Lilly, Novo Nordisk, commissioned clinical trials, contract research and joint research funding: AstraZeneca, Bayer, Novartis, Chinook, Otsuka Medical Devices, Novo Nordisk, Terumo, Variatris, and Kowa, and, Scholarship donations: Otsuka Pharmaceutical, Bayer, Mochida Pharmaceutical, and Boehringer Ingelheim
Its purpose is to prevent microbial contamination of the product and the research compounds it dilutes
Small dense low-density lipoprotein as biomarker for atherosclerotic diseases
This direct route allows for a rapid and comprehensive utilization of this essential vitamin by your body